Wells Fargo & Company Catabasis Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	N/A	-651 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	N/A	-5,739 Reduced 89.81%	651 $1,000
Q1 2021 May 13, 2021	SELL	N/A	-96,588 Reduced 93.79%	6,390 $18,000
Q4 2020 Feb 09, 2021	SELL	N/A	-26,579 Reduced 20.52%	102,978 $220,000
Q3 2020 Nov 05, 2020	BUY	N/A	95,587 Added 281.39%	129,557 $802,000
Q2 2020 Aug 13, 2020	BUY	N/A	33,869 Added 33533.66%	33,970 $219,000
Q1 2020 May 14, 2020	BUY	N/A	101 New	101 $0

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.